The global biotechnology sector is witnessing a paradigm shift driven by Next-Generation Sequencing (NGS). As the "Support Systems Manufacturer," we recognize that the efficacy of genomic analysis is not solely dependent on the sequencer itself, but on the robust, precision-engineered infrastructure that sustains it. From automated library preparation to climate-controlled reagent storage and high-throughput data processing units, the NGS ecosystem requires an unprecedented level of mechanical and electronic integration.
In 2024, the demand for NGS support systems has expanded from high-end research universities to clinical diagnostics, personalized oncology, and agricultural biotechnology. This diversification necessitates support systems that are not only accurate but also scalable and cost-effective. As a leading exporter, we bridge the gap between complex genomic requirements and industrial-grade manufacturing reliability.
Enabling hospitals to perform rapid pathogen identification and oncology profiling with automated support modules that minimize human error.
Supporting large-scale crop genetic testing to ensure food security through high-durability hardware designed for 24/7 operation.
Providing the foundational platforms for individualized therapy development, where data integrity and sample tracking are paramount.
Based in Shenzhen, the "Silicon Valley of Hardware," our manufacturing processes leverage a unique convergence of supply chain density and technological innovation. Shenzhen BioX Medical Co., Ltd. exemplifies the transition from "Made in China" to "Innovated in China." Our NGS support systems benefit from:
Integrating AI at the hardware level for predictive maintenance of NGS support systems, preventing costly downtime during long sequencing runs.
Transitioning toward smaller sample volumes and more efficient reagent usage through ultra-precise support systems.
The move toward "Point-of-Care" sequencing requires compact, ruggedized support systems capable of operating outside traditional laboratory environments.
Furthermore, the integration of Sustainability in laboratory equipment is no longer optional. Our manufacturing philosophy now includes energy-efficient thermal management and recyclable materials for modular components, aligning with global green laboratory initiatives.
A1: Our engineering team utilizes a modular design philosophy. We offer standardized interfaces and custom-tuned mounting and fluidic adapters that are validated against the specific thermal and vibration requirements of each major platform.
A2: As an industry-leading manufacturer, we adhere to ISO 13485 (Medical Devices Quality Management) and CE standards. Every unit undergoes a rigorous 48-hour stress test before export.
A3: Yes, approximately 40% of our capacity is dedicated to OEM/ODM partnerships. We can customize everything from the industrial design (ID) to the specific mechanical tolerances required for proprietary diagnostic kits.
A4: For standard configurations, we maintain a rolling inventory allowing for shipment within 7-14 days. Custom engineering projects typically range from 6 to 12 weeks from prototype to bulk delivery.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
